Category: Uncategorized

Hematologic Oncology & Next-Gen Multispecifics: Roche Inks Potential $1.53 Billion Global Licensing Agreement for Simcere Zaiming’s Preclinical Trispecific T-Cell Engager SIM0660 (CD79a × CD19 × CD3) Targeting Relapsed B-Cell Malignancies and Autoimmune Disorders

03/09/2026 Published by Pharma Biz

Key Development On September 1, 2026, Swiss healthcare conglomerate Roche Holding AG (SIX: RO / ROPC) entered into an exclusive... Read more

Tags: #Global Trends

Agricultural Life Sciences & Global Agrifood Resilience: Bayer Launches First 2 of 10 Projected €500M+ Blockbusters – Advancing Plenexos® Insecticide and Preceon® Smart Corn System Alongside €400M in Operational Cost Savings

03/09/2026 Published by Pharma Biz

Key Development On September 2, 2026, during an institutional investor symposium convened in Iowa, German life sciences conglomerate Bayer AG... Read more

Category: Uncategorized

Tags: #Global Trends

Biopharmaceutical Formulation & Drug Delivery Innovation: Novartis Secures Multi-Target Global Licensing Deal Worth Up to $3.22 Billion for Alteogen’s Hybrozyme™ (ALT-B4) Platform – Enabling Subcutaneous Delivery for Core Biologics

03/09/2026 Published by Pharma Biz

On September 2, 2026, South Korean biopharmaceutical platform developer Alteogen Inc. (KOSDAQ: 196170) announced a major multi-target global licensing agreement... Read more

Category: Uncategorized

Tags: #M&A

AI-Driven Drug Discovery & Computational Oncology: Boehringer Ingelheim Licenses Owkin’s ‘K Pro’ AI Engine and Multimodal Biological Datasets to Accelerate Target Identification in Cancer and Immunology

03/09/2026 Published by Pharma Biz

Key Development On September 2, 2026, biomedical artificial intelligence innovator Owkin, Inc. entered into a strategic licensing and research partnership... Read more

Category: Uncategorized

Tags: #Global Trends

Biopharmaceutical Manufacturing Recovery & Incretin Strategy: Aspen Pharmacare Projects FY27 Normalized EBITDA of at Least 9 Billion Rand ($561 Million) – Accelerating Generic Semaglutide Expansion Across Emerging Markets Alongside Exclusive Mounjaro Commercialization

03/09/2026 Published by Pharma Biz

Key Development On September 2, 2026, South Africa-based pharmaceutical leader Aspen Pharmacare Holdings Ltd. (JSE: APN) issued financial guidance for... Read more

Category: Uncategorized

Tags: #Global Trends

Pediatric Nutrition & Biomanufacturing Infrastructure: Nestlé Commits $393 Million (2 Billion Reais) to Brazil Nutrition & Health Division – Constructing New Infant Formula Plant in Minas Gerais to Localize Supply and Anchor Latin American Exports

03/09/2026 Published by Pharma Biz

Key Development On September 3, 2026, global nutrition and health science leader Nestlé S.A. (SIX: NESN) announced a 2 billion... Read more

Category: Uncategorized

Tags: #Global Trends

Tobacco Regulatory Litigation & Administrative Law: Altria Sues US FDA in Federal Court Demanding Complete Overhaul of Premarket Tobacco Application (PMTA) Framework – Citing Statutory 180-Day Deadlines and Market Distortions Across the $22 Billion Sector

03/09/2026 Published by Pharma Biz

Key Development On September 2, 2026, Altria Group, Inc. (NYSE: MO)—the manufacturer of Marlboro cigarettes in the United States—alongside two... Read more

Category: Uncategorized

Tags: #Global Trends